57 QUANTITATIVE ASSESSMENT OF TUMOR GLUCOSE UTILIZATION FOR PREDICTION OF RESPONSE TO TREATMENT WITH THE EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR GEFITINIB (IRESSA)

ObjectivesSmall molecule inhibitors of the epidermal growth factor receptor (EGFR) kinase have recently been introduced for treatment of non-small cell lung cancer (NSCLC). However, these new drugs are only effective in approximately 10% of patients and there are no diagnostic tests to predict tumor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of investigative medicine 2006-01, Vol.54 (1), p.S89-S89
Hauptverfasser:	Dumont, R. A., Su, H., Bodenstein, C., Czernin, J., Weber, W.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!